| Name | Title | Contact Details |
|---|
Healthcare Dialog is a Pine Brook, NJ-based company in the Business Services sector.
Quest Patent Research Corporation is a New York City based Intellectual Property Asset Management Firm. Quest is incorporated in Delaware (1986), listed on the OTC Bulletin Board, and traded under the symbol QPRC. Quest creates shareholder value through investment and management interests in intellectual property assets, such as patents, trademarks, copyrights, novel inventions and trade secrets. Through our business, shareholders have the opportunity to participate across a broad portfolio of dynamic assets in the burgeoning intellectual property space. Quest provides IP asset owners and stakeholders – including inventors, law firms, estates, small businesses and corporations – with a valued resource for protection, management and monetization of IP assets. Quest partners with owners and affiliates of compelling intellectual property, in both mature and emerging market technologies, to develop and execute a strategic program focused on realizing the full economic value of the IP. We offer a suite of value-added services to owners, IP attorneys, small businesses, and corporations to drive revenue from innovative, distressed, dormant or under-managed IP assets.
At Health Partnership Clinic (HPC), our experienced and compassionate health care providers are focused on caring for you and your familys medical, dental and behavioral health needs—and becoming your"medical home." Our clinics provide quality, integrated health care to children and adults regardless of income or insurance status. In addition, our Shawnee Mission clinic treats only children from newborns (including special need babies) through age 18. HPCs medical, behavioral health, nursing and dental staff represent all walks of life, cultures and races. Several staff members speak multiple languages fluently, including Spanish. Were here to provide quality, affordable and comprehensive care—for you and your entire family.
Antibody and protein biotherapeutics are changing the way physicians treat autoimmune diseases, asthma, and cancer. At Xencor, we apply proprietary protein engineering technologies to develop better biotherapeutics – antibodies that target new biological mechanisms and are more potent, safer and longer lasting – to improve patient outcomes and quality of life. Our XmAb antibody engineering technology dramatically augments natural antibody immune functions while maintaining over 99.5% identity to natural antibodies. This combination of new, highly potent activities while maintaining the beneficial drug features and simplicity of natural antibodies allows us to create differentiated drug candidates with potential for breakthrough performance. The XmAb® platform has resulted in a robust pipeline of antibody product candidates, including eight in human clinical trials being developed by Xencor and by pharmaceutical partners. Xencor is also discovering biologics products that improve the performance of old antibody drugs, known as biosuperiors, to benefit patients, ease compliance and help reduce costs.
Spork is a El Cajon, CA-based company in the Business Services sector.